Holen Sie sich die Stockscreener-App
43.50
0.91%
-0.40
Sanofi Adr Aktie (SNY) Neueste Nachrichten
NOK Stock Slides As ADR Weakness Puts Pressure On Bulls - StocksToTrade
As Biopharma Turns to China, ESG Risks and Geopolitics Remain in Focus - Morningstar
Sanofi Wins FDA Approval for Wearable Injector Form of Blood Cancer Drug - Sahm
SNY Stock Quote Price and Forecast - CNN
NOK Stock Slips Again As ADR Weakness Worries Traders - StocksToTrade
ETFs Investing in Sanofi SA Sponsored ADR Stocks - TradingView
Communiqué de presse : Mise en ligne du document «Q2 2026 aide-mémoire » - GlobeNewswire Inc.
Sanofi stock slides as price lingers below the long-term average - Traders Union
Sanofi Reports Data From Nexviazyme Study, Says It Meets All Endpoints - Sahm
9 New 5-Star Stocks This Week - Morningstar
SNW2 Forecast — Price Target — Prediction for 2027 - TradingView
662283 Forecast — Price Target — Prediction for 2027 - TradingView
EU Launches Antitrust Probe Into Sanofi Over Allegedly Misleading Flu Vaccine Claims - Sahm
Sanofi faces EU probe, shares steady after Friday’s Reuters report - ad-hoc-news.de
Sanofi SA Sponsored ADR Actuals & Estimates (NASDAQ:SNY) - TradingView
Enterprise value to revenue forward of Sanofi SA Sponsored ADR – LSE:0A2V - TradingView
Price to earnings forward of Sanofi SA Sponsored ADR – LSE:0A2V - TradingView
Sanofi: Dupixent Risks Overstated, Valuation Disconnect Creates Opportunity (NASDAQ:SNY) - Seeking Alpha
Price to book forward of Sanofi SA Sponsored ADR – LSE:0A2V - TradingView
Europe Approves Sanofi's Multiple Sclerosis Drug Despite FDA Rejection - Sahm
Sanofi analyst focus on Dupixent and pipeline, shares tracked against Big Pharma peers - AD HOC NEWS
MacroGenics stock rises on $24.5M Sanofi milestone payment By Investing.com - Investing.com Nigeria
Muted Sanofi hits fresh 52-week low, shares trade well below analyst targets - AD HOC NEWS
Form 6K Sanofi ADR For: 22 June By Investing.com - Investing.com Australia
Sanofi-ADR (NASDAQ:SNY): A High-Yield Dividend Stock with Strong Fundamentals - ChartMill
Sanofi S.A. Stock (FR0000127771): Deutsche Bank trims target but sticks with Buy - Ad-hoc-news.de
FDA OKs Sanofi Diabetes Drug In Newly Diagnosed Pediatric Patients - Sahm
Sanofi S.A. Stock (FR0000120578): FDA accelerated approval for Tzield puts diabetes franchise in foc - AD HOC NEWS
Sanofi S.A. Stock (FR0000120578): Valuation Metrics Under the Microscope - Ad-hoc-news.de
Sanofi S.A. Stock (FR0000127771): Stock in focus as no fresh trigger is verified - Ad-hoc-news.de
Sanofi S.A. Stock (FR0000120578): EU vaccine-contract ruling puts legal scrutiny back in focus - ad-hoc-news.de
Sanofi Trial Setback May Reinforce Argenx Vyvgart's Position In CIDP, Analyst Says - Sahm
Sanofi S.A. stock (FR0000127771): Diabetes focus and pipeline news keep Big Pharma in motion - Ad-hoc-news.de
European ADRs Started The Week In The Green - Finimize
Sanofi S.A. stock (FR0000127771): diabetes deal and pipeline focus move into the spotlight - AD HOC NEWS
Sanofi-Owkin Expand AI Collaboration With New Agentic AI Initiative - Sahm
Senior Chinese legislator meets Myanmar's foreign minister - news.cgtn.com
Sanofi (SASY) Stock: Pharma Giant Launches AI Sales Agent Built on Snowflake - MEXC
SNY Stock Price, Quote & Chart | SANOFI-ADR (NASDAQ:SNY) - ChartMill
Sanofi S.A. stock (FR0000120578): analyst consensus steady as ADRs trade in low-40s USD range - AD HOC NEWS
Sanofi S.A. stock (FR0000127771): Analyst consensus points to hold stance as shares hover in low-40s - AD HOC NEWS
Sanofi S.A. stock (FR0000127771): Technical picture and price action on Euronext Paris - AD HOC NEWS
SNYSanofi ADR Options - Finviz
10 International Dividend Aristocrats With Exceptional Dividend Growth Histories - Sure Dividend
Sanofi S.A. stock (FR0000120578): Vaccine and obesity focus after Q1 2026 earnings - AD HOC NEWS
Sanofi S.A. stock (FR0000120578): Q1 results, pipeline focus and outlook for US investors - AD HOC NEWS
0.33%
1.23%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):